Conestoga Capital Advisors, LLC Vericel Corp Transaction History

Conestoga Capital Advisors, LLC

$6.58 Billion
Q2 2024

A detailed history of Conestoga Capital Advisors, LLC transactions in Vericel Corp stock. As of the latest transaction made, Conestoga Capital Advisors, LLC holds 2,041,370 shares of VCEL stock, worth $92.3 Million. This represents 1.42% of its overall portfolio holdings.

Number of Shares

2,041,370

Previous 2,331,310 12.44%

Holding current value

$92.3 Million

Previous $121 Million 22.77%

% of portfolio

1.42%

Previous 1.77%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$41.71 - $52.9 $12.1 Million - $15.3 Million	-289,940 Reduced 12.44%	2,041,370 $93.7 Million
Q1 2024 Apr 26, 2024	SELL	$32.52 - $52.33 $281,298 - $452,654	-8,650 Reduced 0.37%	2,331,310 $121 Million
Q4 2023 Jan 26, 2024	BUY	$30.85 - $37.09 $3.37 Million - $4.05 Million	109,215 Added 4.9%	2,339,960 $83.3 Million
Q3 2023 Oct 27, 2023	SELL	$31.69 - $39.25 $3.34 Million - $4.14 Million	-105,425 Reduced 4.51%	2,230,745 $74.8 Million
Q2 2023 Jul 28, 2023	SELL	$29.0 - $38.37 $1.21 Million - $1.6 Million	-41,777 Reduced 1.76%	2,336,170 $87.8 Million
Q1 2023 Apr 21, 2023	BUY	$23.85 - $31.34 $743,428 - $976,899	31,171 Added 1.33%	2,377,947 $69.7 Million
Q4 2022 Jan 31, 2023	BUY	$17.65 - $27.37 $14.4 Million - $22.4 Million	818,455 Added 53.55%	2,346,776 $61.8 Million
Q3 2022 Oct 24, 2022	SELL	$22.62 - $32.54 $3.99 Million - $5.73 Million	-176,195 Reduced 10.34%	1,528,321 $35.5 Million
Q2 2022 Jul 22, 2022	SELL	$22.88 - $39.45 $20.4 Million - $35.2 Million	-892,294 Reduced 34.36%	1,704,516 $42.9 Million
Q1 2022 Apr 25, 2022	BUY	$31.69 - $43.29 $29.1 Million - $39.8 Million	918,299 Added 54.71%	2,596,810 $99.3 Million
Q4 2021 Jan 21, 2022	BUY	$35.2 - $52.6 $2.48 Million - $3.71 Million	70,498 Added 4.38%	1,678,511 $66 Million
Q3 2021 Oct 22, 2021	BUY	$46.35 - $59.75 $13.7 Million - $17.7 Million	296,071 Added 22.57%	1,608,013 $78.5 Million
Q2 2021 Jul 27, 2021	BUY	$47.2 - $67.81 $59.8 Million - $85.9 Million	1,266,942 Added 2815.43%	1,311,942 $68.9 Million
Q1 2021 Apr 23, 2021	SELL	$30.93 - $59.48 $1.07 Million - $2.07 Million	-34,750 Reduced 43.57%	45,000 $2.5 Million
Q4 2020 Jan 26, 2021	SELL	$18.53 - $31.5 $495,677 - $842,625	-26,750 Reduced 25.12%	79,750 $2.46 Million
Q3 2020 Oct 23, 2020	BUY	$14.68 - $19.12 $82,942 - $108,028	5,650 Added 5.6%	106,500 $1.97 Million
Q2 2020 Aug 03, 2020	BUY	$8.5 - $15.82 $362,950 - $675,514	42,700 Added 73.43%	100,850 $1.39 Million
Q1 2020 Apr 17, 2020	BUY	$7.25 - $19.22 $104,400 - $276,768	14,400 Added 32.91%	58,150 $533,000
Q4 2019 Jan 24, 2020	BUY	$13.77 - $19.2 $373,855 - $521,280	27,150 Added 163.55%	43,750 $761,000
Q3 2019 Oct 25, 2019	BUY	$14.93 - $19.83 $247,838 - $329,178	16,600 New	16,600 $251,000

Others Institutions Holding VCEL

# of Institutions

268

Shares Held

48.4M

Call Options Held

91.1K

Put Options Held

39.8K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.13B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Conestoga Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Conestoga Capital Advisors, LLC with notifications on news.

Account

Conestoga Capital Advisors, LLC Vericel Corp Transaction History